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 ABSTRACT 
Certain minimally invasive cardiology procedures, such as balloon angioplasty and stent 
implantation, critically require that the site of an arterial blockage be crossed by an intraluminal 
guidewire. Plaques resulting in near or totally occluded arteries are known as chronic total 
occlusions (CTOs), and crossing them with conventional guidewires is a significant challenge. 
Among the most promising proposed solutions is the delivery of high power, low frequency 
ultrasonic vibrations to the occlusion site via an intraluminal wire waveguide. The vibrating 
distal-tip of the ultrasound wire waveguide is used to transmit energy to the surrounding plaques, 
tissues and fluids in order to ablate or weaken atherosclerotic plaque. Potential mechanisms of 
interaction with the plaque and adjacent fluids identified in the literature include; (i) direct 
contact with the waveguide distal tip, (ii) subcavitational acoustic fluid pressure fluctuations, (iii) 
cavitation, and (iv) acoustic streaming. This article will summarize developments in this area 
over more than two decades, describing experimental methods for device performance 
characterization, preclinical tests, early clinical investigations and, later, full clinical trials. The 
article will also review theoretical foundations, and numerical models suitable for device design 
and analysis. Finally, important issues for future research and for the development of this 
technology will be considered. 
I.  INTRODUCTION 
Interventions such as Percutaneous Transluminal Coronary Angioplasty (PTCA) and stenting are 
now widely used to restore blood flow through blocked or partially blocked arteries. These 
procedures involve threading a catheter and balloon assembly along a guidewire to the blockage 
site via the arterial lumen. A guidewire is a thin wire with distal geometry specifically designed 
to facilitate navigation through tortuous and branching vessels in order to establish a viable path 
to and across the site of a blockage. It acts as a guiderail for catheters to facilitate the positioning 
of balloon/stent assemblies prior to deployment. Once in position, the balloon is expanded to 
disrupt and displace the plaque in order to restore blood flow through the artery. A wire 
scaffolding structure, known as a stent, may also be expanded by the action of the balloon, and 
its purpose is to hold the artery open, preventing recoil once the balloon is removed.  
A major prerequisite for the use of these interventional procedures, therefore, is the ability to 
first traverse the lesion with an intraluminal guidewire. Depending on the nature of the blockage, 
this may be extremely difficult or impossible with conventional guidewires. Such cases are often 
characterised as chronic total occlusions (CTOs), referring to total closure of the vessel. Several 
novel approaches to overcome this problem have been proposed. Among the most promising is a 
technology involving the delivery of high power, low frequency ultrasonic vibrations to the total 
occlusion site via an intraluminal wire waveguide in order to assist the progression of the 
guidewire across the lesion by a process of plaque ablation or disintegration. 
II.  ATHEROSCLEROTIC PLAQUES 
II.A Atherogenesis 
Atherosclerosis is a thickening of the arterial medial layer which affects the artery by altering 
conduit function and reducing blood flow downstream. There are numerous hypotheses 
describing the origin and progression of the disease, which are beyond the scope of this review. 
It is known to be a time-dependent process with varying stages of severity (1-3) , as confirmed 
by extensive autopsy studies(4). The progression of atherosclerosis can be broadly classified into 
three stages; the fatty streak, the fibroatheromatous plaque and the complicated lesion (5, 6).  
Initially, a fatty streak formed by lipid deposits appears on the intimal surface of arteries but does 
not always progress into a fibroatheromatous plaque(5, 6). The fibroatheromatous plaque 
consists of a necrotic plaque core that is surrounded on one side by the underlying arterial wall 
and bounded on the other by a plaque cap as shown in Figure 1(5). 
The fibroatheromatous plaque is a clearly raised lesion and has a plaque core that consists of a 
mix of collagen fibres, soft lipid and calcified materials and is often known as a fibrous core(6). 
The lesions tend to progress further and are often associated with events such as the plaque core 
rupturing that can lead to haemorrhaging or clotting resulting in further loss or complete loss of 
lumen diameter as shown in Figure 1(5). 
For characterization of the degree of progression of atherosclerosis, some of the minor 
classifications are; superficial calcified nodules, yellow colour (high risk rupture), inter plaque 
haemorrhaging, endothelial dysfunction and remodelling. Some of the major classifications for 
this disease include; active inflammation (macrophage accumulation); thin cap with large lipid 
core; endothelial denudation; and fissured plaque caps.  
There are 6 or so histological classifications described by Stary et al(7) which characterise the 
pathogenesis of an atherosclerotic lesion. 
Initial lesions (I – III) - not detectable by angiography(7)  
• Type I: Lesion contains enough atherogenic lipoproteins to initiate the formation of 
macrophages and macrophage foam cells. 
• Type II: Lesions have appearance of fatty streak, lesion consists primarily of macrophages 
foam cells and lipid laden smooth muscle cells. 
• Type III:  Formation of extracellular lipid droplets and other particles that prevent the 
coherence of some intimal smooth muscle cells. 
Advanced lesions: (IV – VI) (7)  
• Type IV:  Atheroma is formed, lipid core formation by the gathering of the lipid 
droplets/pools, lesion has potential to be symptomatic. Initially is often an eccentric lesion. 
• Type V: Often have lipid core and may also contain fibrous connective tissue, a fibro-
atheroma lesion. 
• Type Va: May be multilayered, several lipid cores separated by fibrous layers. 
• Type Vb: These lesions are largely calcified. 
• Type VI: Lipid core, thick layers of fibrous tissue, with possibility of fissure, hematoma 
and thrombus. These complicated lesions represent much higher morbidity and mortality 
than any other previous lesions. 
Of particular interest are the complicated calcified plaques that have a plaque core and cap that 
are primarily composed of calcified minerals and tough collagen fibres(5). These fall under the 
classification of advanced lesions, partly due to the time they take to develop as they tend to 
occur later in the lesion progression. They are closely associated with chronic total occlusions 
and the success rate with standard procedures involving the mechanical loading of the lesion tend 
to be lower as the rigidity and stiffness of the calcified material and tough collagen fibres can 
resist these applied loads(5). 
II.B Mechanical Characteristics of Atherosclerotic Plaques 
Knowledge of the mechanical and physical properties of various plaques and of the healthy 
arterial wall is of great benefit when developing methods and devices to treat specific lesion 
types. Plaque mechanical properties are largely responsible for problems experienced with the 
use of standard interventional procedures for chronic total occlusions. As biological materials, 
these plaques exhibit complex properties in response to mechanical compression or indentation. 
Specific plaque mechanical properties vary depending on the pathogenesis of the lesion. Early 
stages of the disease exhibit time dependent behaviour under constant mechanical loading (i.e. 
viscoelastic behaviour). Over time, the plaques often exhibit non-linear and inelastic mechanical 
behaviour. Stress-strain curves for loading and unloading of lesions also exhibit hysteresis.  
As time progresses, the lesion can become harder and more brittle. From an experimental 
perspective and given the variability in properties and composition, it is challenging to study the 
mechanical composition of lesions, since they only occur in humans, although some lesions 
types can be artificially induced in animals.  
Some studies have highlighted the mechanical properties of the various types of atherosclerotic 
lesions. Loree et al excised specimens in the circumferential direction and classified them 
histologically as cellular (12 samples), hypocellular (9 samples) or calcified (5 samples)(8). The 
hypocellular plaques were found, on average, to be 1-2 times stiffer than cellular plaques and 
calcified plaques were 4-5 times stiffer than cellular plaques.  
Topoleski and Salunke(9) also report the mechanical behaviour of various plaque types as well 
as contiguous arterial tissue. Segments of human aortoiliac artery were excised during autopsy 
and atherosclerotic lesions (plaque cap and core) removed and cut into small specimens. A 
pathologist classified each specimen as calcified (hard), fibrous (medium) or atheromatous core 
(soft). The samples were subjected to uniaxial compression tests, compressing samples in the 
radial direction. The plaque response was indeed non-linear and the plaques could be 
characterised into three distinct mechanical behaviour patterns. A wide variation in the properties 
of the plaque types was clearly seen, with the hard calcified and fibrous plaques (containing 
some calcium) showing a distinct behaviour, with a considerably stiffer response under 
compression than the medium and soft plaques and the healthy arterial tissue. 
 
II.C Complications Associated with Percutaneous Coronary Interventions 
The American College of Cardiology and American Heart Association has developed a widely 
used classification system for coronary atherosclerotic lesions, treatment options and the 
likelihood of successful treatment. 
• Type A, are most ideal for PTCA, they are less than 10mm long and concentric with 
thrombus absent, drug treatment may be preferable. 
• Type B, lesions are intermediate with 100% occlusion less than 3 months, 10-20 mm 
long, eccentric with some thrombus present.  
• Type C, are the most challenging. They are larger than 20 mm and 100% occluded for 
longer than 3 months(10). 
Early stage lesions can be treated by the typical PTCA. However CTOs are challenging as they 
do not lend themselves to be accessed by the guidewire. Guidewire access and ability to cross the 
lesion is critical to the success of standard dilations procedures and has been reported to be the 
key success indicator in 80% of cases(11). 
In many cases, traditional guidewires are not stiff enough to transverse the tough fibrous cap and, 
indeed, the higher forces applied could carry an associated risk of arterial perforation. Therefore, 
bypass graft surgery is often required, which is a more invasive and less desirable treatment 
option. CTOs are a significant cause for coronary bypass graft surgery referral (12). Not only are 
there problems traversing the CTO, but other issues lie with safe re-entry into the target lumen. 
CTOs are known to have micro-vessels which are formed within the organising thrombi (a result 
of endothelial cells invading the fibrin lattice) that may hinder successful dilation by 
angioplasty(13). 
More advanced lesions can be unstable and potentially hazardous. Death and myocardial 
infarction may occur during CTO angioplasty by shearing off the collateral circulation, thrombus 
formation, perforation, arrhythmia or damaging the proximal epicardial coronary artery or 
proximal side branches(14). 
Chronic total occlusion of a coronary artery is usually defined as “an obstruction of a native 
coronary artery for greater than 30 days with no luminal continuity and with thrombolysis in 
myocardial infarction (TIMI) flow grade 0 or 1” (15). CTOs are generally found in small arteries 
such as those in the coronary artery tree. Chronic total occlusion of the right coronary artery is 
identified in approximately 20% of angioplasty patients, and angioplasty of the CTO is attempted 
in between 10-15% of all cases(16). However, standard techniques, using contemporary 
guidewires, are unsuccessful in approximately 20% of these cases(14, 17). Due to the difficulty 
in dealing with CTOs, a number of patients with these types of lesions are referred to by-pass 
surgery. Success rates in CTOs have steadily increased over the last 15 years because of greater 
operator experience, improvements in equipment, and procedural techniques. However, 
minimally invasive procedures on these types of lesions are the most likely to fail. The majority 
of failures are due to the inability to successfully pass a guidewire across the lesion (89%)(17). 
The ability to cros{{}}s the lesion with a guidewire is the main determinant of interventional 
success and if this cannot be achieved, dilation devices, such as balloon angioplasty and stents, 
cannot gain access to the lesion site to reopen the blockage.  
Even if guidewire access can be achieved, calcifications can lead to a requirement for higher 
balloon pressures during dilation procedures. Siegel et al expressed concern regarding a link 
between high balloon inflation pressures and deep vessel injury and acute procedural 
complications, known as barotraumas, all resulting in greater localised damage and higher 
restenosis rates(18). 
While plaques can develop around the entire lumen structure, resulting in a concentric lesion, 
progression is often eccentric (19-21). Calcified eccentric lesions pose further complications as 
during dilation procedures the rigid calcified side of the artery can potentially remain non-dilated 
while the healthy and often thinner side of the arterial wall over-dilates, meaning that mechanical 
dilation-based interventions with eccentric lesions can be less effective(19). Thus, standard 
interventional procedures work best with concentric lesions as the pressure is divided relatively 
evenly over the lesion. However, dilation of eccentric lesions can be problematic because less 
diseased walls becoming overstretched, increasing the risk of cell necrosis and of tearing, and 
also increasing the risk of restenosis.  
Interventional procedures for these applications should ideally incorporate a means of 
establishing access to the site by navigating the vascular structure, be capable of disrupting total 
blockages due to plaque or thrombus so that a guidewire can be advanced, and also be able to 
selectively damage calcified material while leaving healthy tissue largely unaffected. 
II.D Recent Clinical Progress 
A conventional approach to the problem involves the design of specialized passive guidewires. 
The attributes of typical commercial devices are summarized in Table 1, and are more 
comprehensively reviewed elsewhere(22). Godino et al list the critical characteristics of a 
guidewire as “tip load, tip stiffness guidewire flexibility, ability to shape, shaping memory, shaft 
support, torque transmission, trackability and resistance to tracking of the wire within the 
occlusion”(22). The majority of current guidewires have a main shaft diameter of 0.35mm or 
less. The tips vary from 0.2-0.35mm in diameter, depending on the guidewire. Guidewires fall 
into two classifications; Hydrophilic, which give better tactile feedback, and Non-hydrophilic 
which have lower resistance and better maneuverability (22). Guidewires are also classified as 
soft, intermediate or stiff. Soft wires are normally used for advancement of the catheter and 
crossing occlusions with small lumens. Intermediate wires are used for recently occluded lesions 
or tortuous vessels and stiff wires are used for advancing through CTOs. The suggested method 
for crossing CTOs is to use a soft or intermediate wire to explore the area. A stiffer guidewire 
can then be used to cross the proximal cap if needed. An even stiffer guidewire can again be 
used, if necessary, to cross the CTO and penetrate the distal cap. After the occlusion has been 
crossed the stiff guidewire is then replaced by a soft guidewire(22).  
Lefevre(23) reports that, during procedures involving CTOs, crossing lesions may take 
up to 35 minutes and, with the possibility of guidewire changeovers, entire procedures may take 
1.5 hours. This has implications for the cost of procedures. A soft guidewire with the capability 
of crossing CTOs would offer major advantages, reducing the need for changing wires, and 
therefore reducing the time required for crossing CTOs and increasing the likelihood of success 
for the procedure. 
As an alternative approach, therapeutic ultrasound transmitted via wire waveguides has 
long been identified as a technology with the potential to disrupt atherosclerotic lesions with 
mechanical vibrations transmitted via long, low profile, flexible superelastic wire waveguides. 
Several prototype devices have been developed in an attempt to meet this challenge, including a 
recent 20 kHz ultrasound wire waveguide clinical device, which delivers high power low 
frequency intravascular acoustic energy to the sites of chronic total occlusions(24).  
In early 2005, Flowcardia™ Inc., (Sunnyvale, California, USA), received approval to market this 
ultrasonic waveguide (the Crosser© System) in the European Union for the treatment of chronic 
total occlusions following failure to cross by conventional guidewire techniques(24), and the 
device was granted FDA approval in 2007. 
 The device, based on a monorail concept, is approved specifically for use on chronic total 
occlusions (CTOs). The system used is run at a frequency of approximately 20 kHz and with a 
working length of 146cm. The ultrasound is transmitted via a nickel-titanium wire waveguide to 
a 1mm diameter stainless steel tip.  Apart from the tip, the ultrasound wire and guidewire are all 
housed in a 6F catheter, which acts as an irrigation system. The system works by moving a 
guidewire to the point of the lesion and then the stainless steel tip is advanced over the 
guidewire, fragmenting the lesion as it is pushed forward. 
 In one trial, 55 CTO‟s in 53 patients were treated using the system. The device showed a 
success rate of 76% with no major cardiac events or coronary perforation(25). In a second study 
with 30 lesions in 28 patients success was achieved with 63% of procedures(24). However there 
was one guidewire perforation with no serious adverse effects and one peri-procedural 
myocardial infarction. 
III Fundamentals of High Power, Low Frequency Therapeutic Ultrasound 
Angioplasty 
III.A Background 
In the present context, therapeutic ultrasound refers to the use of high-amplitude low-
frequency ultrasound in clinical interventions (26). The mechanical effect this form of ultrasound 
has on biological tissues was first noted by Conte and de Lorenzi (cited in Atar et al(27)) and its 
effectiveness is based on the fact that at the right combination of frequency and amplitude 
inelastic rigid tissue is vigorously disrupted while elastic tissue can absorb the energy(28, 29). 
It was therefore conceived that this form of energy may be useful in the treatment of 
cardiovascular disease and could potentially have advantages over standard dilation procedures 
in the targeting of specific lesions, especially complicated rigid calcified and fibrous plaques(26). 
Development and testing of experimental devices began as early as the 1970s but were 
extremely limited for practical use. Sobbe et al (30) showed that ultrasound delivered through a 
large diameter wire probe resulted in a longitudinally vibrating distal-tip that had the effect of 
disrupting blood clots in animals. 
During the mid-1980s particular design issues were addressed by two groups, headed by 
Siegel and by Rosenschein, with the goal of making an actual working prototype for initial 
clinical testing and potentially for use in trials. No specific design issues appear in the literature 
and the majority of work focuses on the end clinical results. Some general information is 
reported and is included in this review(31-33). 
Both teams based their design efforts on the system developed by Sobbe et al(30) 
delivering the ultrasonic waves to the lesion via a wire waveguide. This sets up longitudinal 
stress waves and a longitudinal peak-to-peak displacement at the distal-tip of the wire waveguide 
with the potential to disrupt both lesions and clots. 
III.B Ultrasound generation 
In order to displace the distal-tip a wire at the frequencies and high amplitude 
displacements required to cause disruption to lesions a source capable of delivering these 
ultrasonic displacements was required. Both Siegel et al (33) and Rosenschein et al(31, 32) 
describe the use of a piezoelectric transducer as a source for the ultrasound. 
The piezoelectric effect is a property of certain classes of crystalline materials including 
natural crystals of Quartz, Rochelle Salt and Tourmaline plus manufactured ceramics such as 
Barium Titanate and Lead Zirconate Titanates (PZT). When a mechanical pressure is applied to 
these materials a voltage is produced proportional to the pressure applied. Conversely, when a 
voltage is applied the structure changes shape; acting as an electromechanical transducer. These 
shape changes are usually very small, usually in the order of a few microns. 
Dynamic voltages can also be applied which result in a dynamic displacement or shape 
change in the material. In this arrangement the material behaves very much like a mechanical 
system with resonant frequency characteristics. The transducer‟s output will be at a maximum at 
the first resonant frequency, a characteristic of the material and geometric configuration.  Using a 
stack arrangement as shown in Figure 2a, mechanical amplitudes of vibration of 0 –5 μm peak-
to-peak at frequencies less than 100 kHz can be achieved. An ultrasonic generator provides the 
electrical source to drive the transducer at the resonant frequency of the piezoelectric stack (34, 
35). 
These types of transducer are used mostly for sonochemistry applications where agitation 
of chemical and biological samples is required. The frequencies and amplitudes discussed are 
chosen for their ability to cause cavitation, a desirable effect in processing chemical solutions. It 
is largely due to availability for this reason that transducers used for generating the ultrasound in 
intravascular therapeutic ultrasound have been adapted from sonochemistry applications (33). 
For sonochemistry and the generation of cavitation, the displacements (at the frequencies used) 
from the converter (transducer) are still too small for sample processing. An acoustic horn or 
waveguide is usually attached to the transducer to amplify the displacements. 
Acoustic horns are solid metal rods that are designed to couple to the front-end mass of 
the converter. They achieve an increase in output displacement by two means. Firstly, their 
geometry is such that the input wave is compressed through a progressively smaller cross-
sectional area as it travels the length of the rod resulting in a larger displacement at the output. 
This can be clearly seen in both linear and exponentially tapered horns (35) [ 
Secondly, horns can be manufactured to resonate at the frequency of the ultrasonic 
converter. Stepped horns, as shown in Figure 2b, appear most useful for adaptation to the natural 
frequency of the driving transducer and are often easiest to manufacture (36).  
In most practical applications a combination of both stepped and tapered sections are 
used in horn design. Horns are manufactured from materials that have high dynamic fatigue 
strength and low acoustic loss, such as titanium alloys. With a horn attached to the converter 
output amplitudes of vibration greater than 150μm can be achieved and at frequencies less than 
100 kHz. 
Acoustic horns, being of solid metal configuration, lack the flexibility necessary to 
navigate the tortuous vascular geometry. In order to deliver these ultrasonic peak-to-peak 
displacements over sufficient lengths and with the flexibility necessary in minimally invasive 
vascular surgery the idea of using wire waveguides was developed(30, 31, 33). 
III.C Minimal invasive delivery of ultrasound by wire waveguide 
Most of the initial work in the area was based on finding methods to deliver this form of 
ultrasound over waveguide lengths and small diameters capable of being used in surgical 
applications. While little detailed description of the exact design and construction methods is 
given, some general conclusions were drawn from early design and testing. 
Rosenschein et al (32) described the use of a solid flexible aluminium transmission wire 
mechanically coupled to the acoustic horn. Details surrounding the coupling method were not 
included. Fischell et al describe the use of a solid 1.5F (≈ 0.5 mm diameter) titanium wire 
waveguide(37). This system also appears to have been used by Ariani et al (38) and Demer et 
al(28). 
These authors work, in general, detail the use of solid wires manufactured from 
aluminium, titanium or alloys of both to form the transmission member or wire waveguide to 
transmit the ultrasound from the acoustic horn to the lesion location. This ultrasonic transmission 
results in longitudinal displacements at the distal tip of the wire waveguide. 
 In addition both teams located a ball-tip or enlargement at the distal end of the wire. This 
increases the surface area in contact with the lesion and the surrounding fluid. Demer et al (28) 
describes the use of a 2.0 mm diameter ball-tip and Siegel et al(18) a 1.7 mm diameter ball-tip in 
conjunction with the wire waveguide. 
III.D Mechanical effect of wire waveguide tip displacement 
Atar et al (27) suggested that the ultrasonic longitudinal vibration of the wire waveguide 
distal-tip results in four major potentially disruptive events; direct contact ablation, pressure 
wave components, cavitation and acoustic micro-streaming and all these appear to be related to 
the distal-tip displacement amplitude, frequency and geometry(39-42). A diagram of the distal 
section of the wire waveguide and location of disruption mechanisms is shown in Figure 3. 
1. Direct contact ablation 
The oscillating distal-tip of the wire waveguide acts as an ultrasonic reciprocating micro-
drill. Research in ultrasonic micromachining has shown that it is associated with low material 
removal rates by microchipping, and is ideal for ablating brittle ceramic materials(43).  
Direct contact between the oscillating tip and the plaque in the arterial lumen results in 
the fragmentation and ablation of the plaque into microscopic particles and is considered to be 
one of the major effects of ultrasound angioplasty(29). 
Also, it appears that due to the varying material properties of the plaques this form of 
fragmentation technique ablates less distensible rigid calcified and fibrous plaques faster than 
flexible material such as the healthy arterial wall tissue(31). 
2. Acoustic pressure waves and cavitation 
As a result of the direct contact between the oscillating distal-tip and surrounding fluid an 
oscillating acoustic pressure field, superimposed on the ambient pressure, is established around 
the distal-tip. Of particular interest is the fact that if the pressure amplitude is sufficiently high, 
cavitation in the fluid may occur. 
Cavitation occurs when on the negative side of a pressure cycle, such as when the wire 
waveguide tip is retracting, with sufficient amplitude and frequency, suspended gas bubbles in 
the fluid, in channels within the tissue or trapped at solid interfaces expand and collapse with the 
generation of shock waves. Burdic (39) has suggested a simplified relationship between pressure 
and cavitation threshold, discussed in section IV.B. Cavitation is a potentially significant erosion 
event, undesirable in most acoustic applications but necessary in cavitation cleaning baths and 
sonochemistry(39, 40). 
Yock and Fitzgerald(26) concluded that cavitation is a major contributing factor in the 
disruption of plaque and thrombus and that ultrasound ablation of lesions was only present above 
the cavitation threshold and that the rate of disintegration correlates with the amount of power 
delivered above this threshold. 
Makin and Everbach(44) investigated the acoustic pressures developed by an 
ultrasonically vibrating wire waveguide submerged in a liquid with acoustic properties similar to 
blood. The experiment consisted of a 2.46 mm diameter spherical tipped wire oscillating in a 
cylinder of fluid (peripheral arterial phantom) at 22.5 kHz. Their experiment comprised of an 
ultrasonic emitter-receiver submerged in a tube within a 355 mm high acrylic tank with an 
internal diameter of 203 mm. The tank was filled with water or a glycerine-water mix. The 
experiment was described as having a 355 mm high tank filled to 345 mm with fluid. Pressures 
were measured in the range of 12-250 mm from the vibrating tip using an acoustic hydrophone; 
measurements in the vicinity of the tip were restricted due to the limitations of their measuring 
equipment.  
Their results demonstrate two important effects of the ultrasound in vivo: 
1) While the authors were not able to directly measure pressures at the tip, „cavitation 
activity‟ was determined using a 20 MHz focused transducer. They concluded that 
cavitation was evident and related to the distal-tip displacement and the distal tip 
geometry.  
2) A standing wave in the acoustic domain of significant amplitude was also 
detected. They concluded that this standing wave was caused by an impedance 
mismatch between the liquid and the surrounding air. This is similar to the tissue-
air interface encountered in peripheral limbs in vivo, the result of reflection at the 
interface of layers/materials of different acoustic impedance. The sound power 
reflection coefficient is given as(45): 
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 where: αr = sound power reflection coefficient 
   c= speed of sound in fluid medium 
 
Assuming no energy loss, the reflection of the incident energy must correspond to a unity 
value of reflection coefficient. The speed of sound for air and blood/tissue was taken as 340 m/s 
and 1580 m/s respectively and with densities of 1.2 kg/m
3
 and 1050 kg/m
3
 respectively. Using 
equation 9 and the material properties shown, the sound power reflection can be calculated to be 
99.9% at a tissue-air interface.  
If the acoustic field produces sufficiently low pressures, cavitation may occur. This is 
considered to be the most powerful destructive mechanism of the ultrasonic ablation(46). 
3. Acoustic streaming 
Two general forms of fluid motion are set up around an oscillating sphere in a fluid. The 
first can be considered as the oscillatory fluid motion very close to the wall of the tip and, 
secondly, a unidirectional fluid motion in an external acoustic streaming layer as shown in 
Figure 4(40, 41).  
It is the combined presence of direct contact, acoustic pressure waves, cavitation and 
acoustic streaming that led investigators to believe that ultrasound delivered via a wire 
waveguide could disrupt arterial lesions and some analytical theory further describing these 
disruptive mechanisms is discussed later. 
IV. Theoretical Foundations 
This section focuses on the theoretical mechanics which govern the response of a uniform 
rod (waveguide) to a harmonic input displacement and also the fundamental principles of 
acoustic pressure field generation by an oscillating sphere (such as a distal ball-tip) in a fluid.  
IV.A Wire waveguide mechanics 
1. Steady-state vibration of a uniform rod 
The steady-state analytical solution of motion for an undamped longitudinally vibrating 
rod, as shown in Figure 5, subjected to a sinusoidal input vibration motion of  u(t) =b sin (ω(t)) 
is shown in Equation 1 (47). This is similar to the condition set up in ultrasound transmitted via a 
wire waveguide where the distal-tip of the acoustic horn applies a sinusoidal input of particular 
amplitude and frequency to the proximal end of the wire waveguide. 
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The steady-state amplitude of vibration at any point (0 ≤ x ≤ l) can be determined 
although this is an undamped solution and therefore limited. The solution can also be used in the 
determination of resonant response. 
The solution for the resonant response from Equation 1 is shown in Equation 2 where nf  
are the resonant frequencies of vibration for a thin rod of length l  and where the speed of sound 
(longitudinal) in the rod material is c .  
l
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  n = 1, 3, 5…   (2) 
Similarly, for a constant frequency Equation 3 gives us the lengths where resonance 
occurs (n = 1, 3, 5, 7...) and the lengths where non-resonance occurs (n = 0, 2, 4, 6, 8…). This is 
more important to the ultrasound wire waveguide as the displacement input from the distal-tip of 
the acoustic horn is at a constant prescribed frequency determined the ultrasonic generator. 
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The literature describes ultrasound transmission resulting in vibration of the distal-tip of 
the wire waveguide and that the presence of a spherical or near spherical ball-tip enhanced 
transmission to the fluid (44). An analytical solution for the pressure field developed in the fluid 
near to an oscillating sphere exists, proposed by Morse(42), as shown in Equation 4. Figure 6 
illustrates the parameters appearing in this solution.  
IV.B Distal Tip Interactions 
1. Acoustic pressure field around and oscillating sphere 
In this solution the maximum pressure at any point, Pmax, developed in the field 
surrounding an oscillating sphere can be determined.  
   
2
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0
22
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2
r
R
dRfP      (4) 
where f is the frequency of oscillation, d0 is the displacement amplitude of oscillation and 
ρ is the fluid density. This solution shows that pressure amplitudes are at a maximum on the 
surface of the sphere and axially ahead of it. 
2. Cavitation 
From the pressure amplitude field it is possible to infer when and where cavitation is 
likely to occur. While the occurrence of cavitation is dependent on numerous factors such as the 
temperature and the amount of dissolved gas in the fluid, Burdic(39) suggests a simplified 
cavitation threshold intensity, as shown in Equation 5.  
     
c
P
T
2
2
max
     (5) 
According to Perkins(48) this threshold intensity for degassed water at room temperature 
is approximately between 2 and 3 Watts/cm
2
 in the frequency range of 20 – 30 kHz.  
It is worth noting here, that the acoustic intensity required to cause cavitation increases 
significantly above a frequency of 100 kHz, and is one of the main reasons why sonochemistry 
and therapeutic ultrasound is performed at the low-frequency ultrasound bands of between 20 
and 45 kHz. 
3. Acoustic streaming 
Analytical solutions related to acoustic streaming phenomena that occur around a 
vibrating sphere are available in the literature(40, 41). These primarily refer to the boundary 
layer thickness between the inner oscillatory motion and the outer acoustic streaming layer, as 
shown in Figure 4 and will not be discussed here in any great detail.  
There is also, however, a solution for the velocity field of the outer streaming layer given 
by Lee and Wang (41) and this outer streaming layer can be observed experimentally (40). 
4. Recent Progress in Numerical Modelling and Design 
The use of computational modelling is well reported for focussed ultrasound applications, 
predicting the pressure amplitudes, focused field effects and thermal effects in fluid and 
surrounding biological tissues. Frequencies modelled, however, are generally in the Megahertz 
range and with acoustic pressures predictions up to 6 MPa. For high acoustic pressure 
fluctuations, non-linear effects may become significant (49).  
Gentry et al have studied the formation of lesions in bovine muscle by a high frequency 
intracardiac ultrasound ablation catheter, which uses a 10 MHz ring transducer for ablation(50), 
and have developed a finite element model to predict lesion size based on temperature 
distribution. No computational models for predicting lesion or damage formation are yet 
available, however, for high power, low frequency ultrasound wire waveguide procedures, 
despite the recent emergence of such medical devices. 
Gavin et al originally contributed a finite element model of a slender rod subject to high 
frequency mechanical displacements at the proximal end, and presented predictions of the effect 
of wire length on distal output (peak-peak displacements). The model predictions were validated 
by comparison with experimental measurements made using an optical microscope. Figure 7(a) 
shows experimental measurements and finite element analysis predictions of the distal output 
peak to peak displacement amplitude for a range of wire waveguide lengths. This graph reveals 
the critical dependence of output on wire length, and also illustrates the usefulness of the 
numerical model for waveguide design. Figure 7(b) shows the peak to peak displacement 
amplitude at locations along the length of the wire waveguide, also well predicted by the model.  
This study also considered the effect of the damping characteristics of the wire, and showed that 
the NiTi wire waveguides exhibited significant damping over waveguides of approximately 300 
mm length, consistent with a damping factor of 4.5%. In later work, an acoustic fluid structure 
interaction finite element model of the waveguide and surrounding fluid was developed which 
accounted for the interaction of the wire distal tip with the surrounding fluid, and also provided 
predictions of acoustic pressure in the fluid at the distal tip  
Gavin et al present an acoustic fluid-structure model of a therapeutic angioplasty device that can 
predict the pressure amplitudes in the fluid field surrounding a vibrating waveguide tip (51, 52). 
The coupled fluid structure acoustic model assembles the following matrices of equations, where 
the M and K matrices represent mass and stiffness matrices for the solild (subscript S) and the 
fluid (subscript F) respectively.  
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The u and P vectors represent nodal displacements and pressures respectively, and the R 
matrices are coupling matrices representing an effective area associated with each node.  
The model is capable of predicting the effect of waveguide geometry changes, such as wire 
length, on the instruments resonant response, and on the transmission of acoustic energy to the 
surrounding fluids.  
Figure 8 (a) shows the predicted acoustic pressure field around the distal tip of a wire waveguide 
with a 1.0 mm diameter ball tip, and Figure 8 (b) shows a comparison with published results for 
that configuration. This supports the validity of the finite element model for predicting acoustic 
pressure fields generated by the waveguide, which is relevant to the determination of the onset of 
cavitation. Figure 9 (a) illustrates visually the fluid (water) response at various peak to peak 
displacements, showing cavitation developing from around 63 m peak to peak displacement. 
Based on a cavitation threshold of 2.5 W/cm
2
, this agrees with the predictions of the numerical 
model. Figure 9 (b) shows a visualisation of the acoustic streaming phenomenon. The present 
form of the numerical model does not have the capability to predict this effect.  
 
V.  Device Performance Characterisation and Validation 
V.A. Transmission of ultrasound delivered via wire waveguide 
While the theoretical analysis discussed provides valuable insight to the mechanics of 
ultrasound transmission via wire waveguide and through surrounding fluids, they are of limited 
use in analysing complex geometries and conditions. 
The use of the finite element method may be of benefit in assessing effects such as the 
inclusion of specific distal-tip geometries on the waveguide, material damping in the waveguide 
and ultimately the modelling of various distal-tip shapes and their effects on the surrounding 
acoustic pressure field developed, with consequences for the ablation mechanisms 
Further, the method may be applied to the coupling of the waveguide and surrounding 
fluid and modelling the acoustic fluid-structure behaviour of the system. No previous modelling 
of therapeutic ultrasound in small diameter wire waveguides or the coupling with a distal-tip 
fluid appears in the literature. This technique, however, has been used in the modelling of 
ultrasonic acoustic horns (53). 
V.B. Mechanical performance evaluation 
Gavin et al (51) measured distal-tip displacements for short 1.0 mm diameter wire waveguide 
optically using a microscope with a magnification of 40 (Figure 4).  This was carried out over 
various power inputs setting of the generator.  
 Gavin et al (54) examined the 1mm diameter wire waveguides over multiple lengths and 
each length was tested at various power level settings.  It was found that as the power input is 
increased then the output peak-to-peak displacement is also increased. This is not true for all 
wire waveguide lengths; some lengths result in poor or no transmission 
The study suggests that the resonant length of the wires affects the transmission. Wire 
waveguide lengths were examined between 118 and 303mm at intervals of 5mm and again using 
the 1mm diameter wire waveguides at a constant power setting input. 
The study shows that the wire waveguide has specific resonant and anti-resonant lengths.  These 
results also showed stable ultrasound transmission was attained at anti-resonant lengths. The 
performance decreases as the wire length approaches resonant lengths, for the same power input.   
V.C. Prototypes and Clinical Devices 
Ariani et al used an ultrasound waveguide to disrupt human thrombus in vitro and in 
vivo(38). While no exact mode of disruption is determined their results show an inverse 
relationship between acoustic horn distal-tip power and time to dissolve the clots; higher powers 
dissolved the clots in a shorter time period.  
Other authors have published similar results in the treatment of thrombus both in vivo and 
in vitro (32, 55) . 
In addition to this experimental work conducted on thrombus other authors have tested 
the effect of the ultrasound delivery on atherosclerotic lesions. Siegel et al (29) experimentally 
tested a 19.5 kHz system on 50 lesions of which 34% were calcified. The results showed that 
ultrasound delivered via a wire waveguide could recanalise the arteries affected by the lesions 
and that the calcified arteries treated with therapeutic ultrasound could subsequently be dilated at 
lower pressures than before suggesting an overall increase in the distensibility of the lesion.  
This effect is further supported by work conducted by Demer et al (28) when the 
distensibility of calcified lesions was shown to increase following ultrasound delivery. This was 
assessed by pressure-volume inflation curves from a standard dilation catheter as shown in 
Figure 10. Following the administration of ultrasound the inflation curve shifted to the right 
indicating increased distensibility and allowed standard balloon dilation at lower pressures. 
This increase in distensibility is thought to be further increased during intervention and 
immediately afterwards by a phenomenon called vasodilation; the relaxation of the fibres in 
arteries in the vicinity of low frequency ultrasound (37). This is thought to be a biological 
response and beyond the scope of this work but its effects are worth noting. 
V.D. Patent Literature 
This section is not intended to cover all patents but rather to give an oversight of the main 
technical design issues and to show technical progression and suggested solutions. The overall 
external electromechanical systems are similar, resulting from earlier technology, requiring an 
ultrasonic generator, transducer (piezoelectric or magnetostrictive) and acoustic horn attached to 
some small diameter waveguide effectors for insertion into the body. In addition, many other 
design concepts are also patented from pulse mode operation to user interfaces etc.; these are 
considered peripheral and will not be covered in detail. 
Early patents such as that obtained by Balamuth(56) describes a device that utilises ultrasonic 
energy for the removal of warts, tumours and skin cancer but makes no mention of operating 
within blood vessels. Kuris (57) obtained one of the earliest patents to disclose the use of 
vibratory displacements transmitted through a catheter inserted into a blood vessel that is 
surgically exposed. One of the first patents on the line to current approaches, by Boyd(58), 
describes the use of a semi-flexible ultrasonic vibratory catheter for the treatment of atheromas 
including coronary atherosclerosis. In this invention the hollow catheter itself vibrates and has a 
sharpened tip to facilitate the removal of tissue.  
Limitations of these early patents include, open surgery, stiff transmission probes not suited to 
minimally invasive access, associated risks of arterial perforation and other complications. In 
order to overcome these, devices needed to be designed that could deliver ultrasonic vibrations 
via small diameter flexible waveguides (lengths approx. 1.6 m and diameters < 1 mm), similar to 
other minimally technologies, such as balloon dilation catheters. 
As a result, the focus of the detailed technical design, solutions and subsequent patents, in the 
area of minimally invasive ultrasound catheter systems for the ablation and disruption of arterial 
plaques, are in three critical areas: 
1. wire waveguide design and material choice. 
2. method by which the waveguide is connected to the acoustic horn. 
3. wire waveguide distal-tip configuration. 
Two key patents filed in 1989 describe ultrasonic angioplasty systems incorporating flexible 
waveguides, detailed connection methods and peripheral tip designs.  
Bernstein and Rosenschein(59) describe an ultrasonic angioplasty waveguide system using an 
aluminium based alloy (AL-7075 etc.) for the waveguide material in order to reduce attenuation 
of the ultrasonic energy over long working lengths. They state that the distal tip should 
preferably be „flat‟. Their method of connecting the wire waveguide to the acoustic horn uses a 
connector that applies a gripping force to the waveguide by two radially opposing grub screws. 
Heat shrink fitting the connector and waveguide is also mentioned. 
DonMicheal, Siegel and DeCastro (60) describe an apparatus that can induce both longitudinal 
and transverse motions to the wire waveguide. They propose a cobalt-nickel alloy as a suitable 
waveguide material. It is also suggested that a bulbous (enlarged) distal-tip efficiently transfers 
the ultrasonic energy while reducing the risk of „perforating the artery‟. Suggested connection 
methods to the acoustic horn include a „vibration fitting‟ but no specific details are provided. 
Post 1991 many patents became increasingly more detailed.  
In 1995, a patent by Pflueger, Nita et al (61, 62) including some inventors from above (Siegel 
and DeCastro) proposes an ultrasonic device comprising an elongate ultrasound transmission 
member (including tapered waveguides) formed of one or more super-elastic alloys such as NiTi 
(50 at. % Ni). A range of wire waveguide distal-tip designs are disclosed including surface 
finishes with grooves and dimples to enhance material disruption and cavitation. A ferrule grip 
was suggested as a means of connecting the waveguide to the acoustic horn. Also mentioned was 
using the wire waveguide in an „over-the-wire‟ configuration similar to balloon angioplasty and 
more common interventional methods. In 1999, Levin, Rosenschein et al (63) describe a system 
with a waveguide comprising of a series of transitions, multiple wires in parallel and ideal 
transition locations based on the standing wave setup in the waveguide. Waveguides consisting 
of multiple materials transitioning along the length such as aluminium and titanium alloys are 
included. 
Nita and Sarge (62) disclose an ultrasound system with wire waveguides made from a material 
that includes nickel (50.5 – 51.5 at.), having tapered sections and in their embodiment they 
suggest NiTi superelastic alloys. A number of connection methods and distal-tip configurations 
are disclosed, including a balloon to facilitate off-centre positioning of the wire waveguide 
distal-tip. 
 In 2009, Nita et al (64) describe an ultrasound catheter device for the disruption of 
occlusions of blood vessels. In their embodiment they describe a wire waveguide catheter system 
including irrigation ports for cooling of the waveguide, an „over-the-wire‟ configuration and a 
detailed connection system to eliminate lateral movements of the waveguide near the connection 
point. All with the goal of reducing heat in the waveguide and increasing its longevity. 
 
VI. Future Directions 
Much work is still required to further understand this form of ultrasound energy delivery 
and the subsequent affects this has on plaque material and biological response.  
Regarding the fundamental principles of the process, there is a lack of clarity surrounding 
the relative importance of the various proposed disruption mechanisms. Work is needed to 
understand the conditions required to cause cavitation in blood in vivo, and to determine its 
importance in plaque disruption. There is also a need to isolate tissue or plaque effects due 
principally to acoustic streaming, and evaluate the role that this mechanism can play. Of greatest 
importance, perhaps, is the need to develop an understanding of the fracture behaviour of plaque 
caps and lipid pools under contact with a surface vibrating at low ultrasonic frequencies.  
There is a need to develop a greater understanding of the mechanics of wave transmission 
through long, flexible wire waveguides with complex material characteristics (as exemplified by 
Nickel Titanium (NiTi) superelastic shape memory alloys). Significant damping of wave 
amplitude has been observed in straight NiTi wires at low ultrasonic frequencies, and the effect 
of tortuous pathways, necessitating significant bending, require much greater investigation with a 
view to controlling losses. It is essential that the distal tip vibrations can be precisely and 
consistently controlled by the cardiologist, and are not unduly influenced by variable factors 
associated with individual procedures.  
The fatigue of superelastic metals under cyclic strain at low ultrasonic frequencies has not 
been extensively studied, even though the reliability of these devices depends on these 
properties. Designs must, in any case, be configured such that wire fatigue failures (more likely 
at locations of mechanical connection, in the experience of the authors) do not result in being 
unable to retrieve all the distal elements of the device. 
VII. Summary 
Calcified and totally occluded arteries pose significant complications during standard 
balloon angioplasty interventions and stent implantations. The use of therapeutic ultrasound 
transmitted via wire waveguides has been shown in initial clinical testing to be capable of 
disrupting thrombus, calcified and fibrous plaque without significant damage to healthy arterial 
tissue. 
Potential end clinical benefits in the use of therapeutic ultrasound delivered via small 
diameter wire waveguides includes increasing distensibility of calcified plaques with the 
potential of reducing barotraumas and restenosis rates. This technology has also the potential in 
crossing chronic total occlusions, therefore allowing for standard balloon angioplasty and stent 
implantation to be used. 
Little detailed analysis is provided on the design aspects of these devices or how 
ultrasonic displacements are delivered to the distal-tip of these small diameter wire waveguides 
at the frequencies and amplitudes required and the disruption mechanisms these cause. With the 
launch of products to the U.S. and European markets potentially imminent, sophisticated models 
for the design and optimisation of these devices are urgently required. 
This challenge demands a combination of experimental and clinical investigation, and 
computational modelling. A validated finite element model of the mechanical behaviour of a 
small diameter wire waveguide and it‟s interaction with surrounding fluids is necessary. Any 
such model would prove highly beneficial in determining the crucial wire waveguide distal-tip 
displacements and should be capable of predicting when the highly disruptive cavitation events 
occur. 
 Manufacturer Wire Shaft Diameter 
(mm) 
Guidant Whisper 
Pilot 50 
Pilot 150 & 200 
HT Intermediate 
HT Standard 
Cross-IT 100-400 
0.35 
0.35 
0.35 
0.35 
0.35 
0.35 
Boston Scientific Choice PT & PT2 
PT Graphix & P2 
0.35 
0.35 
Cordis Shinobi & Shinobi Plus 0.35 
Medtronic Vascular Persuader 
Persuader 9 
0.35 
0.35 (tip diameter 0.27) 
Abbott Vascular 
Asahi 
Confianza 
Confianza Pro (Conquest) 
Medium 
Miraclebros 
0.35 
0.35 (tip diameter 0.22) 
0.35 
0.35 
Table 1: Variety of guidewires with shaft and tip diameters 
 
Study Frequency of 
Operation 
(kHz) 
Distal Peak-
to-peak 
Displacement 
( m) 
Wire Data 
Rosenschein et 
al [21] 
20 
 
150 ± 25 Aluminium 
Alloy Wire 
1.6mm 
No Ball Tip 
Ariani et al [7] 20 
 
63.5 - 111 Titanium Wire 
.72mm 
2mm Ball-Tip 
Demer et al 
[51] 
 
20 50 ± 25 Titanium Wire 
.5mm 
2mm Ball-Tip 
Makin et al[62] 
 
22.5 200/ 130 Titanium Wire 
1.98/2.46 mm 
Ball-Tip 
Table 2: Waveguide Tip Displacements from the literature 
 
  
Year Patent Number Inventor Assignee 
1969 US 3,433,226 Boyd Aeroprojects Inc. 
1970 US 3,526,219 Balamuth Ultrasonic Systems 
1971 US 3,565,062 Kuris Ultrasonic Systems 
1989 US 4,870,953 DonMicheal, Siegel and 
DeCastro 
- 
1989 WO 89/06515 Bernstein and Rosenschein - 
1995 US 5,397,301 Pflueger, Nita, Siegel, Bacich, 
Bond and DeCastro 
Baxter International Inc 
1999 US 5,971,949 Levin, Saltonstall, Nguyen and 
Rosenschein 
Angiosonics Inc. 
2006 EP 1649,817 A2 Nita FlowCardia Inc. 
2009 US 2009/0216246 Nita, Sarge and Spano FlowCardia Inc 
 
Table 3 Patent Literature 
  
A
g
e 
in
 Y
ea
rs
40
30
20
10
Fatty Streak
?
Fibrous Plaque
Calcification 
Complicated Lesion: 
haemorrhage, ulceration, 
thrombosis
Plaque Core
Plaque Cap
Thrombus
 
Figure 1 Progression of atherosclerosis (adapted from Salunke and Topoleski (5)). 
  
 
Figure 2 (a): Generation of mechanical ultrasonic displacements: converter and acoustic horn 
 
Figure 2 (b): Assembled Acoustic Horn and Converter 
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Figure 3: Schematic of ultrasonic wire waveguide in catheter and the regions surrounding the 
longitudinal vibrating distal-tip where disruptive mechanisms can occur. 
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Figure 4: General features of acoustic microstreaming near a small vibrating sphere. Adapted 
from Nyborg (40) 
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Figure 5: Diagram of a uniform rod, of length l, with an input displacement motion of u = b sin 
ωt. Adapted from Steidel (47). 
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Figure 6: Diagram relating to the pressure field developed around an oscillating sphere. Adapted 
from Nyborg (40). 
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Figure 7 (a)  Wire waveguide distal 
displacement amplitudes (51). 
 
Figure 7 (b) Wire waveguide internal 
displacement amplitudes. (52) 
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Figure 8 (a)  Predicted pressure amplitude field 
around the distal tip of the wire 
waveguide with 1.0 mm spherical 
tip.  
Figure 8 (b) Comparison of predicted pressure 
amplitudes and experimental results 
published by Makin and Everbach 
(44). 
 
 
 
 
 
Figure 9 (a) Images of the distal tip of the 1.0 mm diameter 
wire waveguide at ambient temperature for 
various input power dial settings between 1.5 
and 6.5. (52) 
 
Figure 9 (b)  
Acoustic streaming at distal 
tip (1.0 mm diameter) (52) 
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Figure 10: Example of pressure-volume curves obtained pre (left curves) and post (right curves) 
ultrasound energy application. The rightward shift indicates increased distensibility. 
Data digitised from Demer et al (28) (using xyextract© digitising software). 
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